Tag: NascentBiotech

    Browse our exclusive articles!

    Nascent Biotech Inc (OTCMKTS:NBIO) Continues to Build a Strong Case

    Nascent Biotech Inc. (OTCMKTS:NBIO) is an emerging player in the $4 billion oncology drug development space. NBIO is early-stage – its flagship drug is...

    Popular

    Waller Hawkishness Resists Accommodative Powell: Mar. 28, 2024

    Bond traders are reassessing their monetary policy expectations while...

    Hopping Into Q2 with Key Interim Data Events

    It has been a solid start to 2024 with...

    12,000 Calls Trade in Plains All American Pipeline, L.P. (Symbol: PAA)

    This morning over 11,800 January 17 ’25 calls traded...

    Subscribe